114 related articles for article (PubMed ID: 705636)
1. [Mechanism of action of intestinal hormones].
Kryshen' PF
Ter Arkh; 1978; 50(10):91-4. PubMed ID: 705636
[No Abstract] [Full Text] [Related]
2. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action of circulating amino acids on the function of the digestive system].
Vasilevskaia LS
Vestn Akad Med Nauk SSSR; 1989; (9):90-6. PubMed ID: 2573983
[No Abstract] [Full Text] [Related]
4. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacology of methoclopramide].
Lamotte-Barrillon S; Dentan M
Tijdschr Gastroenterol; 1971; 14(1):7-33. PubMed ID: 4934868
[No Abstract] [Full Text] [Related]
6. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
7. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)].
Loew DM; Grauwiler J; Griffith R; Taeschler M; Weidmann H; Zehnder K
Boll Chim Farm; 1967 May; 106(5):332-71. PubMed ID: 4890002
[No Abstract] [Full Text] [Related]
9. General pharmacological properties of the main metabolite of flosequinan.
Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
[TBL] [Abstract][Full Text] [Related]
11. General pharmacology of the new quinolone antibacterial agent levofloxacin.
Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacodynamic studies with total alkaloids of Uvariopsis guineensis kay Annonacea].
Quevauviller A; Bourrinet P; Bezançon M
Therapie; 1977; 32(2):215-8. PubMed ID: 898129
[No Abstract] [Full Text] [Related]
13. The use of the isolated, homologous perfused canine stomach in the study of the loci and mechanism of action of gastrointestinal hormones.
Cook MA; Kowalewski K; Daniel EE
Mater Med Pol; 1977; 9(2):113-7. PubMed ID: 895185
[No Abstract] [Full Text] [Related]
14. [Pharmacological testing of a new anti-inflammatory agent: 1-(m-trifluoromethylphenyl)-N-nitroso anthranilic acid].
Zoni G; Molinari ML; Banfi S
Farmaco Sci; 1971 Jun; 26(6):525-46. PubMed ID: 5561809
[No Abstract] [Full Text] [Related]
15. [Preclinical study of tricyclic antidepressive agents].
Simon P
Therapie; 1973; 28(2):209-23. PubMed ID: 4766355
[No Abstract] [Full Text] [Related]
16. The adrenergic innervation of the gastrointestinal tract.
Furness JB; Costa M
Ergeb Physiol; 1974; 69(0):2-51. PubMed ID: 4365221
[No Abstract] [Full Text] [Related]
17. [Motility of the digestive system and its neural and humoral regulation].
Zalucki G
Acta Physiol Pol; 1976; 27(6):191-214. PubMed ID: 1020667
[No Abstract] [Full Text] [Related]
18. The interdigestive migrating complex and its significance in man.
Itoh Z; Aizawa I; Sekiguchi T
Clin Gastroenterol; 1982 Sep; 11(3):497-521. PubMed ID: 6754170
[No Abstract] [Full Text] [Related]
19. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
[TBL] [Abstract][Full Text] [Related]
20. Proceedings: Analysis of the motor effect of synthetic motilin on animal and human intestinal smooth muscle in vitro.
Mitznegg P; Strunz U; Domschke W; Wünsch E; Demling L
Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R45. PubMed ID: 1143445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
